-
Sociodemographic Variations in Perceived Social Support Among Adults with Depression in the United States: Results From the National Health and Wellness Survey
Mar 10, 2025, 14:00 PM -
Perceptions of Private Health Insurance Among Households in a Small Island Developing State (SIDS): The Case of Grenada
Mar 10, 2025, 14:00 PM -
Cannabinoids for Symptom Management in Children and Adolescents with Autism Spectrum Disorder: A systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
A Real-World Study on Healthcare Resource Utilisation and Patient Care for People With Transthyretin Amyloid Polyneuropathy
Mar 10, 2025, 14:00 PM -
Qualitative Interviews to Characterize Disease and Treatment Burden at Baseline in Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for the Treatment of Glycogen Storage Disease Type Ia
Mar 10, 2025, 14:00 PM -
Are You Still Not Integrating Gen-AI Frameworks in HEOR Workflows? It's No Longer Optional!
Mar 10, 2025, 14:00 PM -
A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera
Mar 10, 2025, 14:00 PM -
Integrating Metrics of Environmental Sustainability into Economic Evaluations: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System
Mar 10, 2025, 14:00 PM -
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Mar 10, 2025, 14:00 PM -
Clinical Value of Testing for c-Met Protein Overexpression in Patients With Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Risk of Cutaneous Adverse Drug Reactions with GLP-1 Receptor Agonists: Insights from FAERS and Systematic Review
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study
Mar 10, 2025, 14:00 PM -
Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)
Mar 10, 2025, 14:00 PM -
Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development
Mar 10, 2025, 14:00 PM -
Estimated Total Cost of Care (TCC) of First-Line (1L) Fixed-Duration BCL2i versus Treat-To-Progression BTKi Regimens in Patients with Chronic Lymphocytic Leukemia (CLL) in the United States (US): A Population-Based Model
Mar 10, 2025, 14:00 PM -
Blood Phenylalanine (Phe) Levels in Individuals With Phenylketonuria (PKU): A United States Electronic Health Records (US EHR) and Medical Notes Study
Mar 10, 2025, 14:00 PM -
Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective
Mar 10, 2025, 14:00 PM -
More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives
Mar 10, 2025, 14:00 PM -
Comparing the Cost-Utility of Renal Replacement Therapies Delivered to Critically Ill Patients With Acute Kidney Injury in the United States
Mar 10, 2025, 14:00 PM